Welcome to LookChem.com Sign In|Join Free
  • or
4-Benzyl-3,4-dihydro-1H-benzo[e][1,4]diazepine-2,5-dione is a complex organic compound belonging to the class of benzodiazepines. This molecule features a benzene ring fused to a diazepine ring, with a benzyl group attached to the 4-position of the diazepine. The compound has two carbonyl groups at the 2 and 5 positions, which contribute to its reactivity and potential applications in medicinal chemistry. Its chemical structure can be described as a benzodiazepine derivative with a saturated ring and a benzyl substituent, making it a valuable compound for further research and development in the field of pharmaceuticals and chemical synthesis.

1843-49-8

Post Buying Request

1843-49-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1843-49-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1843-49-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,8,4 and 3 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1843-49:
(6*1)+(5*8)+(4*4)+(3*3)+(2*4)+(1*9)=88
88 % 10 = 8
So 1843-49-8 is a valid CAS Registry Number.

1843-49-8Relevant academic research and scientific papers

Solvent-free synthesis of novel benzodiazepine derivatives by a three-component base-catalysed reaction of isatoic anhydride, a primary amine and chloroacetyl chloride

Seydey, Mohsen Khalilpour,Rezaei, Zahra,Homami, Seyed Saied

, p. 286 - 288 (2015/06/02)

Heating isatoic anhydride with a series of primary amines at 150 °C under solvent-free conditions yielded 2-amino-N-alkylbenzamides which, in the same pot, reacted readily with chloroacetyl chloride in the presence of poly(dimethylaminoethyl acrylamide)-modified magnetic nanoparticles (MNP@PDMA), a base catalyst, to give 4-alkyl-1,4-benzodiazepine-2,5-diones in good yields without formation of by-products.

A new entry to [1,2,4]triazolo[1,5-α][1,4]benzodiazepin-6-ones via intramolecular nitrilimine cycloaddition to the cyano group

Broggini, Gianluigi,Garanti, Luisa,Molteni, Giorgio,Zecchi, Gaetano

, p. 14859 - 14868 (2007/10/03)

A series of [1,2,4]triazolo[1,5-α][1,4]benzodiazepin-6-ones of potential pharmacological interest have been synthesised by means of intramolecular nitrilimine cycloadditions to the cyano group.

Synthesis and structure-activity relationships of 3,5-disubstituted 4,5- dihydro-6H-imidazo[1,5-a][1,4]benzodiazepin-6-ones at diazepam-sensitive and diazepam-insensitive benzodiazepine receptors

Ananthan,Clayton,Ealick,Wong,Evoniuk,Skolnick

, p. 479 - 490 (2007/10/02)

A series of imidazobenzodiazepin-6-ones possessing varying substituents at the 3- and 5-positions were synthesized and evaluated for their affinities at diazepam-sensitive (DS) and diazepam-insensitive (DI) benzodiazepine receptors (BzR) in rat cortical and cerebellar membranes. Replacement of an ester substituent at the 3-position with a carbamate, acetylamino, formylamino, isothiocyanato, 2-oxazolinyl, 2-benzoxazolyl, or p- tolylsulfonyl groups lead to >100-fold reductions in affinity at both DS and DI BzR. Replacement of a methyl group on the nitrogen at the 5-position with propyl, allyl, or phenethyl groups also led to significant reductions in affinity at both BzR isoforms. However, incorporation of a benzyl group yields ligands (11f,h,i and 14a-c) with moderate to high affinities at DS BzR, suggesting the presence of a hydrophobic pocket at the receptor site. Introduction of chlorine at the 7-position enhances ligand affinity at DS BzR while chlorine at the 8-position decreases affinity (IC50: 11f, 9.3 nM; 11h, 2.4 nM 11i, 37.8 nM). In contrast, chlorine substitution at the 7- as well as the 8-position increases affinity at DI BzR (K(i): 11f, 112 nM; 11h, 20.2 nM; 11i, 10.9 nM). Compound 11i is among the few described high affinity DI-site ligands with a selectivity comparable to that of Ro 15-4513. Despite their in vitro affinities, compounds 11f, 11h, and 11i exhibit low in vivo activities that may be attributable to unfavorable metabolic or pharmacokinetic properties.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1843-49-8